Being committed to the continuing availability of medicinal products that are pure, safe, potent and efficacious for animals, the AVMA encourages continued development and strengthening of adverse event reporting systems. This includes continued collaboration with constituent professional organizations, industry organizations, government entities and other stakeholders.
See also: Reporting adverse events
AVMA Brochure: Veterinary Biologics
2017 American Veterinary Medical Association